First evidence for helical transitions in supercoiled DNA by amyloid β peptide (1-42) and aluminum -: A new insight in understanding Alzheimer's disease

被引:68
作者
Hegde, ML
Anitha, S
Latha, KS
Mustak, MS
Stein, R
Ravid, R
Rao, KSJ [1 ]
机构
[1] Cent Food Technol Res Inst, Dept Biochem & Nutr, Mysore 570013, Karnataka, India
[2] ITPL, Inst Biotechnol, Ctr Human Genet, Bangalore, Karnataka, India
[3] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiochem, IL-69978 Ramat Aviv, Israel
[4] Netherlands Brain Bank, Amsterdam, Netherlands
关键词
Alzheimer's disease; pUC18 supercoiled DNA; helical transitions; topoisomer separation; B-DNA; Z-DNA; psi-DNA;
D O I
10.1385/JMN:22:1-2:19
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Previously, we evidenced a B --> Z helical change in Alzheimer's brain genomic DNA, leading to a hypothesis that Alzheimer's disease (AD) etiological factors such as aluminum (Al), amyloid beta (Abeta) peptide, and Tau might play a role in modulating DNA topology. In the present study, we investigated the interaction of A1 and Abeta with DNA. Our results show that Abeta(1-42) could induce a B --> psi (Psi) conformational change in pUC 18 supercoiled DNA (scDNA), Abeta(1-16) caused an altered B-form, whereas A1 induced a complex B-C-A mixed conformation. Ethidium bromide binding and agarose gel electrophoresis studies revealed that A1 uncoiled the DNA to a fully relaxed form, whereas Abeta(1-42) and Abeta(1-16) effected a partial uncoiling and also showed differential sensitivity toward chloroquine-induced topoisomer separation. Our findings show for the first time that Abeta and A1 modulate both helicity and superhelicity in scDNA. A new hypothetical model explaining the potential toxicity of Abeta and A1 in terms of their DNA binding properties leading to DNA conformational alteration is proposed.
引用
收藏
页码:19 / 31
页数:13
相关论文
共 41 条
[1]  
Anitha S, 2002, J NEUROMOL MED, V2, P287
[2]  
ANITHA S, 2001, ALZ REP, V4, P121
[3]  
Balakrishnan R, 1998, J PEPT RES, V51, P91
[4]  
BAUER WR, 1980, SCI AM, V16, P243
[5]   Age, neurofibrillary changes, A beta-amyloid and the onset of Alzheimer's disease [J].
Braak, H ;
Braak, E ;
Bohl, J ;
Reintjes, R .
NEUROSCIENCE LETTERS, 1996, 210 (02) :87-90
[6]   NEUROPATHOLOGICAL STAGING OF ALZHEIMER-RELATED CHANGES [J].
BRAAK, H ;
BRAAK, E .
ACTA NEUROPATHOLOGICA, 1991, 82 (04) :239-259
[7]   Interaction of Co, Mn, Mg and Al with d(GCCCATGGC) and d(CCGGGCCCGG): a spectroscopic study [J].
Champion, CS ;
Kumar, D ;
Rajan, MT ;
Rao, KSJ ;
Viswamitra, MA .
CELLULAR AND MOLECULAR LIFE SCIENCES, 1998, 54 (05) :488-496
[8]  
Clements A, 1996, J NEUROCHEM, V66, P740
[9]   INTRANUCLEAR ALUMINUM CONTENT IN ALZHEIMERS-DISEASE, DIALYSIS ENCEPHALOPATHY, AND EXPERIMENTAL ALUMINUM ENCEPHALOPATHY [J].
CRAPPER, DR ;
QUITTKAT, S ;
KRISHNAN, SS ;
DALTON, AJ ;
DEBONI, U .
ACTA NEUROPATHOLOGICA, 1980, 50 (01) :19-24
[10]   A NEUTRAL WATER-SOLUBLE ALUMINUM COMPLEX OF NEUROLOGICAL INTEREST [J].
FINNEGAN, MM ;
RETTIG, SJ ;
ORVIG, C .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1986, 108 (16) :5033-5035